🟢 Kailera Therapeutics, Inc. is trading 4.6% up today, extending a rebound from its June 16 decline

Kailera Therapeutics, Inc. is trading at $20.02, up 4.6%, extending a rebound that started after its June 16 decline.

• Recent news and filings show no fresh company-specific developments, clinical updates, or analyst calls tied to the current move.
• The price action appears driven by technical trading and a continued bounce rather than a new fundamental catalyst.
• The stock continues to exhibit volatility typical for newly listed biotech shares following its large April 2026 IPO.